Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure

Overview of attention for article published in Circulation Journal, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 1 X post from an account with 4,311 followers.

【SBP>125mmHgで軽・中等度腎機能低下の日本人急性心不全に対し，ヒトリラキシン2製剤 "Serelaxin" は安全。５日間非重篤・14日間重篤有害事象はプラセボと差なし：46例ランダム化二重盲検第II相試験】 Circ J http://t.co/JaVACbUg8C

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.